Connect with us

Media OutReach

Asia Pacific Employers Lead in Health, Wellbeing Personalisation and Governance: Aon Study

Published

on

SINGAPORE – Media OutReach Newswire – 19 August 2025 – Aon plc (NYSE: AON) has released its 2025 Global Benefits Trends Study, spotlighting Asia Pacific (APAC) as a region driving innovation in employee benefits strategy. With 518 global HR professionals and 103 APAC-headquartered companies participating, the study reveals a strong regional focus on employee health, personalisation and governance—setting APAC apart from global peers.

“As organisations navigate economic uncertainty and rising employee expectations, the ability to deliver personalised, equitable and cost-effective benefits is a strategic differentiator,” said Tim Dwyer, head of Human Capital for APAC at Aon. “Our survey signals APAC is leading the way in aligning benefits strategy with workforce needs. Through innovative, data-driven analytic programmes, businesses are building resilient, future-ready programs for their workforce.”

Key Findings for APAC
1. Health and productivity a strategic priority
APAC is the only region to rank “health and productivity of employees” among its top five strategic priorities. This reflects the region’s reliance on service labour and the outsized impact of workforce wellbeing on global supply chains.

2. Personalisation gains ground
Thirty-two percent of leading multinationals participating in the survey have global guidelines requiring local markets to introduce benefit choice. APAC firms, in particular, are more likely to offer flexibility in annual leave and career development, aligning with employee preferences. Moreover, 65 percent of employees at multinational firms are willing to sacrifice current benefits for better personalisation.

3. Technology-enabled benefits delivery
Sixty percent of leading multinationals (that is multinationals who have a global benefits strategy, an effective governance framework that is formally adopted and endorsed by senior management, reviewed and updated on a periodic basis and access to comprehensive data in most countries) rely heavily on technology to deliver personalised benefits experiences. APAC companies are early adopters of artificial intelligence (AI) for benefits selection and wellbeing support, with 28 percent planning to implement AI-driven solutions.

4. Cost containment remains central
Thirty-one percent of companies from the global survey are considering remarketing or changing providers, though only 37 percent are investing in wellbeing initiatives, suggesting a gap between strategic intent and execution.

5. Governance and strategy execution
Leading APAC organisations are three times more likely to have formal governance committees and senior management endorsement of their global benefits strategy and are 2.5 times more likely to have global benefit guidelines outlining preferred design and financing approaches.

“Health and productivity of the workforce are crucial, and the large size of the populations in this region means that small changes can have a large impact,” said Alan Oates, head of global benefits for APAC at Aon. “Prioritising health and productivity of employees reflects the critical importance of workforce in the region to the supply chain for many multinational organisations. Organisations across the region must continue to adapt their employee benefits strategies to meet evolving workforce expectations and economic challenges as they strive to remain competitive. This study underscores the importance of aligning benefits strategy with workforce needs while managing manage rising costs and governance complexity — especially in a region as diverse as APAC.”

About the Study: The 2025 Global Benefits Trends Study surveyed HR leaders with global responsibilities across multiple regions. The findings provide a comprehensive view of how multinational companies are evolving their benefits strategies to remain competitive in a complex global environment.

Download the full report: Aon 2025 Global Benefits Trends Study

Hashtag: #Aon

The issuer is solely responsible for the content of this announcement.

About Aon

(NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.

Follow Aon on , , and . Stay up to date by visiting Aon’s and sign up for news alerts .

Disclaimer
The information contained in this document is solely for information purposes, for general guidance only and is not intended to address the circumstances of any particular individual or entity. Although Aon endeavours to provide accurate and timely information and uses sources that it considers reliable, the firm does not warrant, represent or guarantee the accuracy, adequacy, completeness or fitness for any purpose of any content of this document and can accept no liability for any loss incurred in any way by any person who may rely on it. There can be no guarantee that the information contained in this document will remain accurate as on the date it is received or that it will continue to be accurate in the future. No individual or entity should make decisions or act based solely on the information contained herein without appropriate professional advice and targeted research.

Advertisement

Media OutReach

Zuellig Pharma Acquires Cialis® (Tadalafil) from Lilly in three additional markets in Asia

Published

on

SINGAPORE – Media OutReach Newswire – 12 March 2026 – Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has acquired all rights, title, and interest in and to Cialis® (Tadalafil), a leading men’s health product from Eli Lilly and Company (“Lilly”) in Hong Kong, Macau and South Korea.

Following the acquisition, Zuellig Pharma will now own the trademarks, marketing authorizations and license manufacturing know-how for Cialis®, a treatment for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH), in 11 markets in Asia, with the expansion of its ownership into three additional markets beyond the original eight. Zuellig Pharma will also continue to promote and distribute the brand in these markets.

The expanded ownership of Cialis® will widen accessibility of the drug to a significant population of men in Asia who are affected by ED and BPH. The acquisition also aligns with Zuellig Pharma’s strategic priority of building a strong portfolio of owned prescription healthcare products as an integrated healthcare solutions company.

“Our acquisition of Cialis® in three additional markets builds on the strong foundation we established two years ago and highlights our proven success in scaling trusted brands effectively through our commercial capabilities and deep expertise. As we broaden our footprint, we remain focused on delivering sustainable growth and advancing our purpose of making in-demand healthcare solutions more accessible to communities in Asia,” said John Graham, CEO of Zuellig Pharma.
Hashtag: #ZuelligPharma #EliLillyandCompany #Cialis #MensHealth #Healthcare #Pharmaceuticals


The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, commercialization, and clinical trial support services, underpinned by a strong culture of innovation to support the growing healthcare needs in this region. The company was founded a hundred years ago and has grown to become a multibillion-dollar business covering 18 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

Continue Reading

Media OutReach

Ingdan Powers Embodied AI with Humanoid-Style Brain-Cerebellum Chipset to Boost Robotics Ecosystem

Published

on

HONG KONG SAR – Media OutReach Newswire – 12 March 2026 – Ingdan, Inc. (“Ingdan” or the “Company”, stock code: 400.HK; with its subsidiaries (the ”Group”)), a core supplier in the AI computing power supply chain and a leading application technology solutions provider, announces continued progress in strengthening its humanoid robotics ecosystem through an integrated embodied intelligence IC product matrix, supporting the industry’s transition toward large‑scale commercialization.

2026 is widely regarded as a milestone year for humanoid robotics, in which humanoid robots transition from laboratory prototypes and demonstration performances to large‑scale mass production. At CES in January, NVIDIA announced the commercial launch of its physical‑AI core platform Jetson Thor. Tesla is scheduled to officially release the mass‑production engineering version of its Optimus (V3) humanoid robot by the end of March, with plans to initiate million‑unit‑level production lines by the end of 2026—an inflection point widely regarded as the “Model 3 moment” of the humanoid robotics industry. At the same time, Chinese robotics companies such as AGIBOT, Unitree, and Fourier Intelligence have already deployed products at scale in warehousing and logistics scenarios.

Against this backdrop, the upstream hardware focus of the humanoid robotics industry is increasingly converging on “Brain-Cerebellum” collaboration and low‑latency, multi‑joint real‑time control, which are essential to achieving coordinated, smooth, and human‑like robotic motion. During the CMG Spring Festival Gala, robots from multiple companies demonstrated complex coordinated movements and dexterous hand operations, further highlighting the value of this technical direction.

D‑Robotics, originating from the AIoT and robotics division of Horizon Robotics, focuses on edge‑side embodied intelligence solutions characterized by high computing power, integrated computation and control, and low latency. Leveraging its parent company’s long‑term experience in intelligent driving, D‑Robotics has established a precise position in humanoid robot “Brain-Cerebellum” coordination and real‑time joint control.

In November 2025, D‑Robotics unveiled its flagship robotics computing platform S600, with an official release planned for the end of the first quarter of 2026. The S600 platform features a highly integrated humanoid‑style “Brain-Cerebellum” chipset architecture. Its “Brain” configuration combines an 18‑core A78AE CPU with a proprietary Nash‑architecture BPU, delivering 560 TOPS (INT8) edge computing power and supporting efficient deployment of VLA, VLM, LLM, and locomotion models. Its “Cerebellum” configuration integrates a 6‑core R52+ MCU, providing high‑reliability, real‑time motion control.

By integrating CPU, BPU, and real‑time MCU capabilities into a single SoC, S600 enables a closed‑loop architecture encompassing perception, decision‑making, and real‑time action control. This design addresses a key industry challenge in which many edge AI processors lack embedded real‑time MCUs and rely on external controllers, resulting in excessive latency. The integrated MCU supports high‑frequency, high‑precision PWM signal generation based on FOC algorithms, enabling precise motor control and contributing to stable rhythm and natural gait.

The S600 platform has been adopted by multiple robotics companies such as Fourier Intelligence, Booster Robotics, X Square Robot, and ROBOTERA, supporting applications that require stable multi‑joint coordination and smooth motion performance.

Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.

D‑Robotics is a core product line Ingdan distributes . Building on D‑Robotics’ products and combined with its own technical services—such as multi‑sensor fusion development, real‑time closed‑loop tuning, Quantization‑Aware Training (QAT) support, simulation testing, and modular SOM customization—the Group has supported sophisticated customers including Galbot and ROBOTERA, continuously enriching the robotics industry ecosystem.

Looking ahead, Ingdan will continue to focus on the humanoid robotics sector. Leveraging an IC product matrix centered on NVIDIA Jetson and D‑Robotics platforms, the Company aims to further strengthen its AI intelligent terminal capabilities and continue supporting the iterative development of embodied intelligence products.

For investor and media enquiries
Please email to **@****an.com

Hashtag: #Ingdan #Chips #humanoid #D‑Robotics #NVIDIA #Tech

The issuer is solely responsible for the content of this announcement.

Ingdan, Inc.

Ingdan, Inc. (00400.HK) is a core supplier in the AI computing power supply chain and an application technology solutions provider covering both AI infrastructure and AI intelligent terminals. The Company represents a broad portfolio of international semiconductor manufacturers, including NVIDIA, Xilinx, Intel, AMD, and SanDisk, as well as numerous domestic chip vendors. It serves hundreds of robotics manufacturers and Tier‑1 customers and has formed a comprehensive embodied intelligence ecosystem.

Continue Reading

Media OutReach

Snow, Ice, and Performance: 2026 Changan Global Testing Season Arrives in Europe with Back-to-Back Winter Events

Published

on

  • European dealers and journalists experienced the CHANGAN DEEPAL S05 AWD at 2026 Changan Global Testing Season this February.
  • With intelligent AWD and advanced ADAS, the CHANGAN DEEPAL S05 AWD offered uncompromising safety and control on winter roads.

Saalfelden, Austria – Media OutReach Newswire – 12 March 2026 – Following extreme cold tests in Yakeshi, China, the 2026 Changan Global Testing Season made its European debut this February with the Changan Winter Experience in Courmayeur and the Winter Test Drives in Saalfelden. The all-electric CHANGAN DEEPAL S05 AWD was tested on snow and ice—familiar conditions for European drivers—offering dealers and journalists an immersive introduction to Changan’s electric mobility vision through dynamic drives.

Three-time Olympic gold medalist and Milano Cortina 2026 Ambassador Deborah Compagnoni joined the event in Courmayeur, testing the CHANGAN DEEPAL S05 AWD. Her career—defined by determination, control, and reliability—reflects Changan’s core values. “I felt that the principles of trajectory and speed in skiing apply to driving. With this model, you gain confidence on challenging terrain,” she said.

Snow-Validated Performance: The CHANGAN DEEPAL S05 AWD

Tested in Europe, the CHANGAN DEEPAL S05 AWD demonstrated controllable dynamics, reliable traction, and enhanced safety—highlighting its cutting-edge AWD and ADAS. The system adapts seamlessly: ECO/COMFORT modes prioritize RWD efficiency, while AWD will engage automatically when sensors detect slip, high torque demand, or extreme cold below -25°C. SPORT mode delivers permanent 50:50 torque for sharper response. SNOW mode maintains balanced torque with optimized slip control for confident driving on low-grip surfaces.

The intelligent AWD system delivers up to 320 kW power, 502 Nm torque, and 0–100 km/h acceleration in 5.5 seconds. It also improves hill climbing with a 40% gradient capability, ensures stability by actively balancing power to prevent skidding, and enables safer cornering at higher speeds through optimized grip and vehicle dynamics.

Changan Standard: Proven in the Alps, Bound for the World

Changan Standard is defined by a principle: forged in extremes, built for every day. From Yakeshi to the Alps, the test environments are selected to verify specific performance attributes—safety technologies, chassis response, all-wheel-drive calibration, and ADAS in low-grip scenarios. The objective of 2026 Global Testing Season is not to demonstrate extremes, but to confirm consistency: that the same level of safety, control, and stability demonstrated will be replicated in Mexico, Thailand, and Saudi Arabia.

Hashtag: #Changan

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending